Bacteria isolated from hospital, municipal and slaughterhouse wastewaters show characteristic, different resistance profiles.


Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
01 Dec 2020
Historique:
received: 06 05 2020
revised: 09 07 2020
accepted: 09 07 2020
pubmed: 9 8 2020
medline: 8 10 2020
entrez: 9 8 2020
Statut: ppublish

Résumé

Multidrug-resistant bacteria cause difficult-to-treat infections and pose a risk for modern medicine. Sources of multidrug-resistant bacteria include hospital, municipal and slaughterhouse wastewaters. In this study, bacteria with resistance to 3rd generation cephalosporins were isolated from all three wastewater biotopes, including a maximum care hospital, municipal wastewaters collected separately from a city and small rural towns and the wastewaters of two pig and two poultry slaughterhouses. The resistance profiles of all isolates against clinically relevant antibiotics (including β-lactams like carbapenems, the quinolone ciprofloxacin, colistin, and trimethoprim/sulfamethoxazole) were determined at the same laboratory. The bacteria were classified according to their risk to human health using clinical criteria, with an emphasis on producers of carbapenemases, since carbapenems are prescribed for hospitalized patients with infections with multi-drug resistant bacteria. The results showed that bacteria that pose the highest risk, i. e., bacteria resistant to all β-lactams including carbapenems and ciprofloxacin, were mainly disseminated by hospitals and were present only in low amounts in municipal wastewater. The isolates from hospital wastewater also showed the highest rates of resistance against antibiotics used for treatment of carbapenemase producers and some isolates were susceptible to only one antibiotic substance. In accordance with these results, qPCR of resistance genes showed that 90% of the daily load of carbapenemase genes entering the municipal wastewater treatment plant was supplied by the clinically influenced wastewater, which constituted approximately 6% of the wastewater at this sampling point. Likewise, the signature of the clinical wastewater was still visible in the resistance profiles of the bacteria isolated at the entry into the wastewater treatment plant. Carbapenemase producers were not detected in slaughterhouse wastewater, but strains harboring the colistin resistance gene mcr-1 could be isolated. Resistances against orally available antibiotics like ciprofloxacin and trimethoprim/sulfamethoxazole were widespread in strains from all three wastewaters.

Identifiants

pubmed: 32763594
pii: S0048-9697(20)34423-5
doi: 10.1016/j.scitotenv.2020.140894
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Carbapenems 0
Waste Water 0
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

140894

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Esther Sib (E)

Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany; Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

Franziska Lenz-Plet (F)

Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Vanessa Barabasch (V)

Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Ursula Klanke (U)

Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Mykhailo Savin (M)

Institute of Animal Sciences, University of Bonn, Bonn, Germany.

Norman Hembach (N)

Karlsruhe Institute of Technology (KIT), Institute of Functional Interfaces (IFG), Microbiology/Molecular Biology Department, Karlsruhe, Germany.

Anna Schallenberg (A)

Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Katja Kehl (K)

Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Cathrin Albert (C)

Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Mike Gajdiss (M)

Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Nicole Zacharias (N)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

Heike Müller (H)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

Ricarda Maria Schmithausen (RM)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

Martin Exner (M)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

Judith Kreyenschmidt (J)

Institute of Animal Sciences, University of Bonn, Bonn, Germany; Department of Fresh Produce Logistics, Hochschule Geisenheim University, Geisenheim, Germany.

Christiane Schreiber (C)

Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.

Thomas Schwartz (T)

Karlsruhe Institute of Technology (KIT), Institute of Functional Interfaces (IFG), Microbiology/Molecular Biology Department, Karlsruhe, Germany.

Marijo Parčina (M)

Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Gabriele Bierbaum (G)

Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany. Electronic address: gabi.bierbaum@ukbonn.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH